awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36864736-789FB755-293E-4035-B4DB-FF2C6CFA7EB6
Q36864736-789FB755-293E-4035-B4DB-FF2C6CFA7EB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36864736-789FB755-293E-4035-B4DB-FF2C6CFA7EB6
Evolving approaches to patients with advanced differentiated thyroid cancer
P2860
Q36864736-789FB755-293E-4035-B4DB-FF2C6CFA7EB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36864736-789FB755-293E-4035-B4DB-FF2C6CFA7EB6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1da70c2495793f30bd7873510560eb0e4af00182
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr